Refractec – The Tale of an Evolution in Need of a Revolution

Refractec was really a revolution at the time in terms of reshaping the cornea, but was in need of an evolution of how we think of the cornea. This technology if introduced today would have had an even more robust life.


Thomas Frinzi

Tom Frinzi

Thomas Frinzi is Senior Vice President of Abbott’s vision business, which includes a broad ophthalmology portfolio across the areas of cataracts, refractive surgery (LASIK) and eye health products. Prior to joining Abbott, Mr. Frinzi held a number of leadership positions in ophthalmology and medical device companies.

View Full Profile